Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ONCY
ONCOLYTICS BIOTECH INC.
NASDAQ
$0.86
▲ UP 0.78% (0.01)

KEY STATISTICS

Market Cap$85.97 M
52w High$1.51
52w Low$0.73
Dividend Yield—
Frequency—
P/E-2.52
Volume671.58K
Shares Out.100.36M

COMPANY

LEADERSHIP

Jared Kelly
CHIEF EXECUTIVE
Jared Kelly

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 5, 2001
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
29

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.—
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2018-05-25Reverse2:19

PRICE

$0.86 ▲ UP 0.78% (+$0.01)
OVERLAYS
$0.82$0.84$0.85$0.879:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.86

About Oncolytics Biotech Inc.

http://www.oncolyticsbiotech.com ↗

Oncolytics Biotech Inc., a Calgary-based biopharma company founded in 1998, develops cancer treatments like pelareorep, and collaborates with Merck KGaA, Pfizer, and PrECOG on immunotherapies for solid tumors and breast cancer.

INDUSTRY

Biotechnology

A PRODUCT ONCOLYTICS BIOTECH INC. IS KNOWN FOR

Pelareorep
Pelareorep

Pelareorep, Oncolytics Biotech's lead investigational immunotherapy, is in late-stage trials for cancers like breast and pancreatic, aiming to activate the immune system, and has received multiple FDA Fast Track Designations.

COMPETITORS

COMPETITOR
AMGN COMPARE
CADL COMPARE
CGON COMPARE
GNLX COMPARE
REPL COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
QQQS
0.40% · 107.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
4.06%
HOLDERS
99
TOP 12 OF 99 · RANKED BY POSITION SIZE
Marshall Wace, Llp
745.4K sh · $708.08K
Renaissance Technologies LLC
715.8K sh · $607.6K
Morgan Stanley
426.5K sh · $372.78K
Sandbox Financial Partners, LLC
400.0K sh · $339.52K
Citadel Advisors LLC
382.1K sh · $534.87K
Xtx Topco Ltd
260.9K sh · $247.83K
Seeds Investor LLC
258.3K sh · $225.76K
Goldman Sachs Group Inc
208.7K sh · $292.18K
International Assets Investment Management, LLC
208.2K sh · $181.92K
Connective Capital Management, LLC
185.7K sh · $176.41K
Tocqueville Asset Management L.P.
149.0K sh · $126.47K
Everhart Financial Group, Inc.
138.2K sh · $117.27K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
McAdory John Bearden
— · 500.0K shares
2026-06-01
★
DIRECTOR:
Glover Stephen C.
— · —
2026-06-01
★
DIRECTOR
Parsons James T.
Purchase · 10.0K shares
2026-03-11
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Kelly Jared
Purchase · 5.0K shares
2026-03-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
IMMX$13.94COMPARE
ZNTL$3.80COMPARE
WHWK$4.62COMPARE
MGNX$4.13COMPARE
SRZN$22.42COMPARE
COYA$4.59COMPARE
CLNN$4.23COMPARE
TIL$7.58COMPARE